This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
In 1963, Easson and Russell27 reported that 13% of 822 patients with Hodgkin's disease were alive at 15 years and were presumably cured by radiotherapy. Curative therapy became the primary clinical objective in Hodgkin's disease, replacing symptomatic amelioration. Improved clinical staging and histological classification facilitated therapeutic management.
In a report by Peters et al,28 of 1,131 patients treated with radiotherapy from 1931 to 1969, the five-year survival rate was 43%. During the period from 1965 to 1969, with the completion of five years of observation of 64 patients, the survival was 59%; it is stated that 40% of these patients were in stages I and II of the disease.
The radiotherapy center at Stanford29 reports 275 patients with Hodgkin's disease, of whom 54 have completed five years of observation. The five-year survival was 73%; however, 80% of the patients were in stages I and II of the
Shimkin MB. Evaluation of Recent Results. JAMA. 1973;223(2):169–170. doi:10.1001/jama.1973.03220020035010
Customize your JAMA Network experience by selecting one or more topics from the list below.